FLBL | OXLC | FLBL / OXLC | |
Gain YTD | 3.351 | -18.259 | -18% |
Net Assets | 1.19B | 1.83B | 65% |
Total Expense Ratio | 0.45 | 12.45 | 4% |
Turnover | 12.68 | 21.57 | 59% |
Yield | 7.29 | 26.15 | 28% |
Fund Existence | 7 years | 15 years | - |
FLBL | OXLC | |
---|---|---|
RSI ODDS (%) | 3 days ago26% | 3 days ago90% |
Stochastic ODDS (%) | 3 days ago13% | 3 days ago90% |
Momentum ODDS (%) | 6 days ago44% | 3 days ago65% |
MACD ODDS (%) | 3 days ago22% | 3 days ago71% |
TrendWeek ODDS (%) | 3 days ago43% | 3 days ago75% |
TrendMonth ODDS (%) | 3 days ago38% | 3 days ago78% |
Advances ODDS (%) | 6 days ago48% | 28 days ago89% |
Declines ODDS (%) | 10 days ago35% | 4 days ago76% |
BollingerBands ODDS (%) | 3 days ago15% | 3 days ago90% |
Aroon ODDS (%) | 3 days ago31% | 3 days ago87% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PVIVX | 49.42 | 0.70 | +1.44% |
Paradigm Micro-Cap | |||
ASVDX | 10.25 | 0.07 | +0.69% |
American Century Small Cap Value R6 | |||
VSMPX | 286.40 | 1.25 | +0.44% |
Vanguard Total Stock Mkt Idx Instl Pls | |||
GILLX | 23.90 | 0.10 | +0.42% |
Goldman Sachs Enhanced U.S. Equity Inst | |||
FBTAX | 28.16 | 0.01 | +0.04% |
Fidelity Advisor Biotechnology A |